RWM
AGN

RBA Wealth Management’s Allergan plc AGN Stock Holding History

RBA Wealth Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-3,887
Closed -$688K – 103
2020
Q1 		$688K Buy
3,887
+749
+24% +$141K 0.6% 53
2019
Q4 		$598K Buy
3,138
+581
+23% +$105K 0.41% 59
2019
Q3 		$430K Buy
2,557
+1,302
+104% +$212K 0.33% 61
2019
Q2 		$210K Buy
+1,255
New +$174K 0.16% 85

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

RBA Wealth Management's AGN Position: Q2 2020 in Review

RBA Wealth Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 3,887 shares — an estimated $688K sold.

RBA Wealth Management first reported a position in AGN in Q2 2019 and held it in 4 quarters. The position peaked at $688K in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • RBA Wealth Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • RBA Wealth Management sold 3,887 Allergan plc shares in Q2 2020, an estimated $688K.
  • RBA Wealth Management first reported a position in Allergan plc in Q2 2019 and held it in 4 quarters.
  • RBA Wealth Management's Allergan plc position peaked at $688K in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on RBA Wealth Management's 13F filing for Q2 2020, filed 29 Sep 2020.